Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5)

Antiviral Research

Volumn 52, Issue 1, 2001, Pages 63-75

  Ruff, Michael R ^a   Melendez Guerrero, Loyda M ^b   Yang, Quan en ^c   Ho, Wen Zhe ^d   Mikovits, Judy W ^c   Pert, Candace B ^a   Ruscetti, Francis A ^c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Entry inhibitor; HIV 1; Macrophage; Peptide T; Therapeutic

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; PEPTIDE T;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; MACROPHAGE; MICROGLIA; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; T LYMPHOCYTE; VIRION; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN;

ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; BIOLOGICAL ASSAY; CELLS, CULTURED; CHEMOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FETUS; FLOW CYTOMETRY; GENES, REPORTER; HELA CELLS; HIV CORE PROTEIN P24; HIV-1; HUMANS; LUCIFERASES; MACROPHAGES; MICROGLIA; PEPTIDE T; RECEPTORS, CCR5; TIME FACTORS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034869072     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(01)00163-2     Document Type: Article

References (62)

1. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
2. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
3. Peptide T sequences prevent neuronal cell death produced by the envelope protein (gp120) of the human immunodeficiency virus
4. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide
5. VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death
6. Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein
7. Cytokine release from microglia: Differential inhibition by pentoxifylline and dexamethasone
8. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
9. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
10. Conformational study of the threonine-rich C-terminal pentapeptide of peptide T
11. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
12. Identification of a major co-receptor for primary isolates of HIV-1
13. Identification of human macrophage inflammatory proteins-1 and -1 as a native secreted heterodimer
14. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
15. Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands
16. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes
17. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo
18. Relation of phenotype evolution of HIV-1 to envelope V2 configuration
19. Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line
20. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
21. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment
22. Identification of a major co-receptor for primary isolates of HIV-1
23. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates
24. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
25. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
26. Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome
27. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
28. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
29. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
30. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization
31. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication
32. Treatment of early AIDS dementia in intravenous drug users: High versus low dose peptide T
33. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor
34. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS
35. Pathogenesis of human immunodeficiency virus
36. The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1
37. Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts
38. Molecular cloning of AIDS-associated retrovirus
39. HIV-1 entry inhibitors: Evading the issue
40. HIV gp120 inhibits the somatotropic axis: A possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting
41. Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity
42. AIDS and its dementia as a neuropeptide disorder: Role of VIP receptor blockade by human immunodeficiency virus envelope
43. A 500 MHz study of peptide T in a DMSO solution
44. Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line
45. The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex
46. Anti-chemotactic activities of peptide-T: A possible mechanism of actions for its therapeutic effects on psoriasis
47. Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxis
48. Regulation of the human chemokine receptor CCR1. Cross-regulation by CXCR1 and CXCR2
49. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120
50. Peptide T[4-8] is core HIV envelope sequence required for CD4 receptor attachment
51. CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis. Relationship to vasoactive intestinal polypeptide
52. Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: Role of the V1/V2 domains
53. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
54. Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands
55. HIV envelope-CD4 interaction not inhibited by synthetic octapeptides
56. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy
57. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140
58. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120
59. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses
60. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression
61. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: Relevance for HIV-1-associated dementia
62. The HIV protein, GP120, activates nuclear protein kinase C in nuclei from lymphocytes and brain